Achievement of weight loss with canagliflozin, sitagliptin and glimepiride in combination with metformin or metformin plus sulfonylurea in patients with Type 2 diabetes

被引:0
|
作者
Stein, L. [1 ]
Thompson, G. [2 ]
Diels, J. [3 ]
Thilakarathne, P. [3 ]
Girod, I. [2 ]
机构
[1] Janssen Cilag Ltd, Med Affairs, High Wycombe, Bucks, England
[2] Janssen Cilag Ltd, Outcomes Res, High Wycombe, Bucks, England
[3] Janssen, HEMAR EMEA, Beerse, Belgium
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:145 / 145
页数:1
相关论文
共 50 条
  • [1] Canagliflozin in Asian patients with type 2 diabetes on metformin alone or metformin in combination with sulphonylurea
    Ji, L.
    Han, P.
    Liu, Y.
    Yang, G.
    Van, N. K. Dieu
    Vijapurkar, U.
    Qiu, R.
    Meininger, G.
    [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (01): : 23 - 31
  • [2] Rosiglitazone in combination with glimepiride plus metformin in type 2 diabetic patients
    Kiayias, JA
    Vlachou, ED
    Theodosopoulou, E
    Lakka-Papadodima, E
    [J]. DIABETES CARE, 2002, 25 (07) : 1251 - 1252
  • [3] Economic evaluation of canagliflozin versus glimepiride and sitagliptin in dual therapy with metformin for the treatment of type 2 diabetes in Italy
    Ravasio, Roberto
    Pisarra, Patrizia
    Porzio, Roberto
    Comaschi, Marco
    [J]. GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2016, 3 (02) : 92 - 101
  • [4] COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS SITAGLIPTIN WHEN ADDED TO METFORMIN AND SULFONYLUREA IN TYPE 2 DIABETES IN CANADA
    Sabapathy, Suthakar
    Neslusan, Cheryl
    Yoong, Kim
    Teschemaker, Anna
    Johansen, Pierre
    Willis, Michael
    [J]. JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2016, 23 (02): : E151 - E168
  • [5] Evaluation of Efficacy and Tolerability of Glimepiride and Metformin Combination: A Multicentric Study in Patients with Type-2 Diabetes Mellitus, Uncontrolled on Monotherapy with Sulfonylurea or Metformin
    Pareek, Anil
    Chandurkar, Nitin B.
    Salkar, Harsha R.
    Borkar, Mangala S.
    Tiwari, Dharmendra
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2013, 20 (01) : 41 - 47
  • [6] Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus
    Gonzalez-Ortiz, Manuel
    Guerrero-Romero, Jesus F.
    Violante-Ortiz, Rafael
    Wacher-Rodarte, Niels
    Martinez-Abundis, Esperanza
    Aguilar-Salinas, Carlos
    Islas-Andrade, Sergio
    Arechavaleta-Granell, Rosario
    Gonzalez-Canudas, Jorge
    Rodriguez-Moran, Martha
    Zavala-Suarez, Etelvina
    Ramos-Zavala, Maria G.
    Metha, Roopa
    Revilla-Monsalve, Cristina
    Beltran-Jaramillo, Teresita J.
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2009, 23 (06) : 376 - 379
  • [7] Efficacy, Safety and Treatment Satisfaction of Glimepiride vs Sitagliptin in Combination with Metformin in Type 2 Diabetes Mellitus
    Kumar, Subodh
    Pathak, Anuj Kumar
    Saikia, Dibyajyoti
    Kumar, Amish
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (12) : FC07 - FC10
  • [8] Safety and Efficacy of Sitagliptin Added to the Combination of Sulfonylurea and Metformin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
    Round, Elizabeth
    Shentu, Yue
    Golm, Gregory T.
    O'Neill, Edward A.
    Gantz, Ira
    Engel, Samuel S.
    Kaufman, Keith D.
    Goldstein, Barry J.
    [J]. DIABETES, 2013, 62 : A299 - A299
  • [10] Empagliflozin as add-on to metformin plus sulfonylurea in patients with Type 2 diabetes
    Haering, H. U.
    Merker, L.
    Christiansen, A. Vedel
    Roux, F.
    Salsali, A.
    Kim, G.
    Meinicke, T.
    Woerle, H. J.
    Broedl, U. C.
    [J]. DIABETIC MEDICINE, 2015, 32 : 89 - 89